For example, mutations in KRAS are common in lung, colon, and pancreatic cancers, those in NRAS predominate in melanoma, and HRAS mutations are commonly seen in bladder, head and neck, and skin cancers [6–9]. This evidence concerns the gene KRAS and melanoma.